Phase III study of VR647 in patients with Asthma
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Vectura
- 06 Sep 2017 According to a Vectura media release, this trial will support a New Drug Application (NDA) filing anticipated in 2020.
- 21 Mar 2017 According to a Vectura media release, company plans to initiate this study in 2H 2018.
- 31 May 2016 New trial record